Abstract: Aggregates of the protein a-synuclein are the main component of Lewy bodies, the hallmark of Parkinson's disease. a-Synuclein aggregates are also found in many human neurodegenerative diseases known as synucleinopathies. In vivo, a-synuclein associates with membranes and adopts a-helical conformations. The details of how a-synuclein converts from the functional native state to amyloid aggregates remain unknown. In this study, we use maltosebinding protein (MBP) as a carrier to crystallize segments of a-synuclein. From crystal structures of fusions between MBP and four segments of a-synuclein, we have been able to trace a virtual model of the first 72 residues of a-synuclein. Instead of a mostly a-helical conformation observed in the lipid environment, our crystal structures show a-helices only at residues 1-13 and 20-34. The remaining segments are extended loops or coils. All of the predicted fiber-forming segments based on the 3D profile method are in extended conformations. We further show that the MBP fusion proteins with fiber-forming segments from a-synuclein can also form fiber-like nano-crystals or amyloid-like fibrils. Our structures suggest intermediate states during amyloid formation of asynuclein.
Introduction a-synuclein is a neuronal protein involved in many human neurodegenerative diseases, for example, Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB). [1] [2] [3] [4] A common feature in these diseases is that a-synuclein forms insoluble filamentous inclusions known as Lewy bodies in patients' neuronal tissues. The term synucleinopathies was introduced to encompass all diseases involving a-synuclein deposition.
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In vitro, a-synuclein has been shown to be unfolded in aqueous solution and to be a-helical or b-structural in apolar organic solvents. 9 In a lipid environment, for example, in the presence of lipid vesicles 10 or detergent micelles, 11 most residues of the protein are in a-helical conformations. The function of a-synuclein has not been fully defined, but current evidence points to vesicle trafficking regulation where a-synuclein associates with membranes and interacts with SNARE complexes. [12] [13] [14] Therefore, in this study, we refer to the membrane-bound a-helical conformation as a native-like reference state of a-synuclein. In diseases, a-synuclein forms typical amyloid fibrils, with a cross-b diffraction pattern indicating that b-sheet containing structures predominate. 15, 16 How the protein converts from the functional a-helix-rich state to the pathological bsheet-rich amyloid state is important for understanding the cause of the diseases and to search for possible cures.
The structure of a-synuclein, both in the membrane-bound state and in the amyloid state, has been extensively studied by solution NMR, 11 solid state NMR, 17, 18 electron paramagnetic resonance (EPR), 10, 19, 20 and X-ray crystallography. 21 Ulmer et al. provided the first full-length atomic model of a-synuclein in SDS micelles using solution NMR. The first 93 residues form two anti-parallel helices with a turn spanning residues 37-44. 11 Jao et al.
showed that in the presence of synthetic lipid vesicles the first 90 residues form a continuous long a-helix using EPR. 20 Together with the follow-up studies, [22] [23] [24] Progress has been made in structural characterization of a-synuclein in the membrane-bound state as well as in the amyloid state. However, structural information regarding the transition is very limited. 25 Here, we present our crystallographic studies on segments of a-synuclein. We used maltose-binding protein (MBP) as a carrier to crystallize four segments of a-synuclein, which in total correspond to the first 72 residues. The crystal structures reveal a combination of a-helices, extended loops and coils, suggesting an intermediate between the a-helix-rich membrane-bound conformation and the b-sheet rich amyloid conformation. To test this hypothesis, we carried out fibrillation experiments with the fusion proteins and showed that they can form fiber-like nano-crystals or amyloid-like fibrils after incubation. Our study suggests a possible application of crystallography for characterizing intermediate structures of amyloid proteins.
Results

Prediction of fiber-forming segments in a-synuclein
Human a-synuclein has 140 residues, with seven 11-mer repeats (denoted R1-R7) and an acidic C-terminal tail [ Fig. 1(A) ]. One of the repeats, R6, is less similar to the others [ Fig. 1(B) ]. R6 is within the NAC (non-A beta component) region of a-synuclein.
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We used the 3D profile computer algorithm 26, 28 to identify fiber-forming segments of a-synuclein [ Fig.  1(C) ]. This algorithm scores successive, overlapping six-residue segments by their Rosetta energy 27 in a structural profile of a canonical steric zipper. 30 Energy-favored hits were found at three regions of a-synuclein: residues 14-20 within R1, residues 47-56 within R4, and residues 67-95 corresponding to the NAC region. Except the two hits close to the Nterminus (residues [14] [15] [16] [17] [18] [19] [20] , the predictions are in agreement with EPR and solid state NMR data that have suggested the core of a-synuclein fibrils.
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Crystal structures of a-synuclein segments fused to MBP
We first attempted to crystallize full-length a-synuclein with MBP as a carrier, but the longest crystallizable construct turned out to be the first 42 residues fused to MBP. Unfortunately, the density of asynuclein was not traceable for that particular construct.
Other fusion proteins that we tested, formed from a-synuclein segments fused to the C-terminus of MBP, are summarized in Table I . Among the crystallized fusion proteins, four showed traceable electron density of a-synuclein and are presented here: MBP-aS [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , MBP-aS , MBP-aS , and MBPaS 58-79 [ Fig. 2 (A) and Table II , is disordered and cannot be seen in the electron density map.
The fusion of MBP-aS 32-57 starts from R3 and ends before R5. The first 5 residues of R3 are not traceable and the remaining residues form a coiled loop with several turns. The predicted fiber-forming region in R4 starts at G47, which is indicated by a red arrow [ In all fusion structures, a-synuclein segments extend out of the globular MBP and interact with symmetry related MBP molecules [ Fig. 2(B) ]. Combining four crystal structures, we can trace the first 72 residues of a-synuclein, except residue E57. Modeled regions from the four structures are almost continuous with the only overlap being at residues 37-42 from MBP-aS and MBP-aS (Supporting Information Fig. S2 ). Twenty-eight out of 72 residues (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) are in a-helical conformations, in contrast to 65 out of 72 residues being a-helical in the presence of SDS micelles. 11 The remaining residues form various loops and turns, indicating structural flexibility of a-synuclein. Four out of five predicted fiber-forming segments are in extended loops. The one exception is 51 GVATVA 56 , which forms a coiled loop. Apparently, these segments are capable Figure 1 . Domain architecture of a-synuclein and prediction of fiber-forming segments by the 3D profile method. A: Domain architecture of a-synuclein. The seven 11-mer repeats are colored in orange and red, with red highlighting R6, the repeat that is less similar to the other repeats. The C-terminal acidic tail is in green. All other segments are in blue. B: Sequence comparison of the seven 11-mer repeats of a-synuclein. Residues are colored as follows: basic, red; aromatic, blue; polar, yellow; non-polar, green. C: Prediction of fiber-forming segments by the 3D profile method. 26 The Rosetta energy 27 of steric zipper-like self-association was calculated by scanning through the sequence with a six-residue window. The energy was not calculated if the window included a proline. Energies below À23 kcal/mol (indicated by a gray line) are likely to form amyloidlike fibrils according to previous experience. 28 The calculated energies of segments are colored in rainbow from blue to red for low to high predicted propensity for fiber formation. Above the histogram, the sequence of a-synuclein is colored as the domain diagram in (A).
of fiber formation, but the MBP isolates them from identical segments, with which they could form selfcomplementary steric zipper structures. In the absence of these self-interactions, they take up extended or coiled conformations.
Fibrillation of the fusion proteins
To test whether the crystal structures reflect an intermediate state during fibrillation of a-synuclein, we conducted fibrillation experiments with each of our fusion proteins as well as with the controls of wild type MBP and a-synuclein. Thioflavin T, which fluoresces when bound to amyloid fibrils, was incubated with each construct, shaken at 37 C and fluorescence was monitored as a function of time (Fig.  3) . As expected, wild type a-synuclein showed a typical nucleation dependent kinetic curve with a lag time around 5 h. Wild type MBP did not show any fluorescence, but fusion proteins with full-length asynuclein (MBP-aS ) and the first 79 residues of a-synuclein (MBP-aS 1-79 ) did. The lag time of the two fusion proteins were 90 and 60 h, respectively, much longer than that of wild type a-synuclein, showing that the fused, globular MBP slows fibrillation. MBP-aS 1-79 was the shortest construct that could recapitulate typical thioflavin T (ThT) fluorescence of amyloid in our fibrillation experiments. None of the other fusion constructs tested showed fluorescence (Fig. 3) .
To validate the presence of amyloid-like fibrils from the fibrillation experiments, we examined all samples by negative-stain EM after 2 weeks of incubation (Fig. 4) . As expected, wild type a-synuclein and MBP-aS showed typical unbranched amyloid-like fibrils [ Fig. 4(B) Fig. 4(A) ], but Figure S1 , PDB code 3Q29. are reminiscent of nano-crystals that we have observed for other fiber-forming segments. [30] [31] [32] MBP without a-synuclein fusion did not fibrillize or form nano-crystals [ Fig. 4(B) upper left]. Therefore, the nano-crystals result from the fusion of MBP to a-synuclein segments. Nano-crystals were also observed for MBP-aS , but they were not fiberlike [ Fig. 4(B) upper right]. This may be due to the fact that the fusion of MBP-aS starts at R2 and ends at R3, which does not include any fiber-forming segments [ Fig. 1(C) ].
Discussion
MBP fusion has been successfully applied to crystallize numerous proteins that were otherwise resistant to forming X-ray grade crystals. 33 
calculated using a random set containing 5% reflections that were not included throughout structure refinement. otherwise cause fibrillation. The crystal acts as an isolation chamber, bathed in a polar medium that does not necessarily promote a-helix formation, allowing the preamyloid segment to take up a favored conformation in the absence of binding proteins. This favored conformation may reflect the structure that is intermediate between the all a-helical native-like structure and the all b-sheet, fibrillar structure. A caveat in interpreting the structure of these preamyloid segments is that its conformation can be influenced by interactions with its own MBP fusion partner or other MBP molecules in the crystal.
As shown in Table I and Figure 2 , we crystallized four MBP-a-synuclein fusion constructs and were able to trace the first 72 residues of a-synuclein from the four structures. Figure 5 shows a composite model, pieced together from these four crystal structures. All fiber-forming segments predicted by the 3D profile method were found in loops rather than in fiber-like structures. This is as expected because no identical segments are available in proximity in the crystal structures. However, when the MBP fusions were incubated for fibrillation, nano-crystals were observed, typical of fiber-forming segments reported before. [30] [31] [32] This shows that the fiber-forming segments are capable of forming fibers. We, therefore, refer to them as prefiber-forming segments.
In our fusion crystal structures, a-synuclein segments form some interactions with symmetryrelated MBP molecules, but their conformations do not appear to be determined by these interactions [ Fig. 2(B) ]. The two a-helices (residues 1-13 and 20-34) form hydrogen bonds to either water or MBP molecules mainly through their side chains. The conformations of the loop regions (residues 14-19 and 35-72) appear to be maintained mainly through backbone hydrogen bonds to water molecules: among a total of 60 intermolecule hydrogen bonds, 47 are backbone hydrogen bonds and 32 out of 47 are to water molecules. This suggests that the conformations of the loop regions are not completely determined by MBP molecules, and therefore may reflect an intrinsic propensity of residues 14-19 and 35-72 to be flexible and extended in a polar medium. When the prefiber-forming segments in these regions are freely exposed in similar solution conditions, and when self-association is not prevented by crystal packing, amyloid-like fibrils will form as observed in our fibrillation experiments. Our structures also suggest that residues 1-13 and 20-34 are less flexible and tend to maintain native a-helical conformations in the polar medium. The higher propensity of the first 30 residues to maintain a-helix conformation in a lipid medium was demonstrated by NMR. 36 It is known that many proteins interact with asynuclein in vivo. 1, [37] [38] [39] [40] Our crystal structures may also represent such an ''interacting state'' of a-synuclein. Although in our crystals a-synuclein segments interact with bacteria MBP [ Fig. 2(B) ], which is biologically irrelevant, these interactions may offer insight into the way that the synuclein molecule can convert to a partially opened conformation, permitting interactions of some of its segments with various other protein partners, whereas other segments of a-synuclein maintain protected a-helical conformations.
Intermediate states of amyloid proteins are important for understanding the initiation of fibrillation and the etiology of disease. In our fusion crystals, the packing of the MBP molecules prevents self-association of the fiber-forming segments in a-synuclein, thereby trapping intermediate states.
When linked together, these intermediate states are suggestive of a partially opened conformation that could exist during amyloid formation and also during the formation of interactions of a-synuclein with other proteins.
Materials and Methods
Plasmid construction, protein expression, and purification
All a-synuclein segments were cloned into pMALc2X vector (New England Biolabs, Ipswich, MA) between SacI and SalI sites, which left a three-residue linker ( 369 SSS 371 ) between MBP and each synulcein segment. The fusion proteins were expressed in BL21-Gold (DE3) competent cells (Agilent Technologies, Santa Clara, CA). Proteins were purified by affinity chromatography, followed by gel filtrations. Detailed procedures are described in Supporting Information.
Crystallization, data collection, and structure determination
All crystals of fusion proteins were obtained using hanging drop vapor diffusion method. Crystals were grown at 18 C for a week before cryoprotection and flash freezing in liquid nitrogen. X-ray diffraction data were collected at the Advanced Photon Source (APS). Reflections were integrated and scaled using either DENZO/SCALEPACK 41 or XDS/XSCALE 42 program packages. Molecular replacement was performed using the CCP4 program PHASER 43, 44 with PDB model 1ANF. The models were built manually using COOT 45 and were refined using PHENIX. 46 Coordinates and structure factor amplitudes have been deposited in the PDB with accession code 3Q25, 3Q26, 3Q27, 3Q28, and 3Q29. Detailed crystallization conditions are provided in Supporting Information.
Electron microscopy
Samples of 5 lL volume were spotted directly on freshly glow-discharged carbon-coated electron microscopy grids (Ted Pella, Redding, CA). After 3 min incubation, grids were rinsed twice with 5-lL distilled water and stained with 1% uranyl acetate for 1 min. Specimens were examined in a JEM1200-EX electron microscope at an accelerating voltage of 80 kV. Images were recorded digitally by wide angle (top mount) BioScan 600W 1 Â 1K digital camera (Gatan, Pleasanton, CA).
Fibrillation assay
Proteins at a concentration of 200 lM were incubated in a buffer containing 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10 mM maltose, and 10 lM thioflavin T, with constant shaking (900 rpm, 1 mm diameter) at 37 C for 2 weeks. All reactions were conducted in a 96-well plate with a total volume of 150 lL for each reaction and were monitored in a Varioskan Flash Multimode Reader (Thermo Scientific, West Palm Beach, FL). Thioflavin T fluorescence at 482 nm was measured at 10 min interval by excitation at 440 nm. After the incubation, 5 lL samples were taken out of each well for electron microscopy examination.
